There is one clinical trial.
This study will investigate the impact of the Double-Trunk Mask (DTM) on the reduction of oxygen titration in patients with severe hypoxemia.
Description: The O2 output will be adjusted to maintain a SpO2 of 94% using both systems for administering O2. The O2 flow will be read from the position of the ball in flow meters.Measure: Change in O2 output Time: At baseline and 30 minutes after wearing both systems
Description: A Likert scale from 0 to 5 will be used to measure the subjective comfort of the patient while wearing the standard interface for administering O2 and/or the DTMMeasure: Comfort with the interfaces Time: 30 minutes after wearing both systems
Description: Oxygen tension (PaO2) in mmHg will be analyzed from a sample taken from the arterial systemMeasure: Changes in PaO2 Time: At baseline and 30 minutes after wearing DTM
Description: Carbon dioxide tension (PaCO2) in mmHg will be analyzed from a sample taken from the arterial system.Measure: Changes in PaCO2 Time: At baseline and 30 minutes after wearing DTM
Description: Potential of Hydrogen (pH) will be analyzed from a sample taken from the arterial system.Measure: Changes in pH Time: At baseline and 30 minutes after wearing DTM
Description: Respiratory rate is measured during one minute by visual inspection.Measure: Changes in respiratory rate Time: At baseline and 30 minutes after wearing both systems
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports